ARCAD Stock Analysis: Arcadis | AS
Engineering & Construction | AS, Netherlands | Market Cap: 3.692m EUR | 12M Return: 1.3% | NL0006237562 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.87M
EPS Trend: -3.8%
Qual. Beats: 0
Rev. Trend: 45.8%
Qual. Beats: 5
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Arcadis N.V. is a global design, engineering, architecture, and consultancy firm headquartered in Amsterdam, the Netherlands, with operations spanning the Americas, Europe, the Middle East, and Asia Pacific. Founded in 1888 and formerly known as Heidemij NV, the company organizes its activities across four reportable segments: Places, Mobility, Resilience, and Intelligence. Its service offering covers asset management, business advisory, cost and commercial management, design and engineering for infrastructure such as highways, railways, bridges, tunnels, and water utilities, as well as digital environmental, health, safety and sustainability (EHS) solutions, project management, mobility systems, climate and resilience advisory, and water supply and wastewater treatment services. As a member of the Construction & Engineering sub-industry within the Industrials sector, Arcadis operates on a project-based professional services model, typically generating revenue through long-term consultancy contracts with public sector clients, utilities, and private developers on natural and built-asset projects. Its broad international footprint and diversified end-market exposure are characteristic of large-scale European engineering consultancies, which compete on technical expertise rather than asset ownership.
- US infrastructure bill fuels Americas segment revenue growth
- Energy transition and climate adaptation projects expand Resilience order pipeline
- Acquisition integration and wage inflation pressure operating margins
| Net Income: 203.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.20 > 1.0 |
| NWC/Revenue: 6.28% < 20% (prev 8.27%; Δ -1.98% < -1%) |
| CFO/TA 0.10 > 3% & CFO 375.0m > Net Income 203.0m |
| Net Debt (1.29b) to EBITDA (435.0m): 2.96 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.4m) vs 12m ago -5.19% < -2% |
| Gross Margin: 15.20% > 18% (prev 17.93%; Δ -2.73% > 0.5%) |
| Asset Turnover: 127.4% > 50% (prev 128.0%; Δ -0.68% > 0%) |
| Interest Coverage Ratio: 3.49 > 6 (EBIT TTM 346.0m / Interest Expense TTM 99.0m) |
| A: 0.08 (Total Current Assets 1.91b - Total Current Liabilities 1.60b) / Total Assets 3.84b |
| B: 0.23 (Retained Earnings 887.0m / Total Assets 3.84b) |
| C: 0.09 (EBIT TTM 346.0m / Avg Total Assets 3.85b) |
| D: 0.38 (Book Value of Equity 1.05b / Total Liabilities 2.79b) |
| Altman-Z'' = 2.28 = BBB |
| DSRI: 1.06 (Receivables 1.47b/1.40b, Revenue 4.90b/4.94b) |
| GMI: 1.18 (GM 17.93% / 15.20%) |
| AQI: 1.02 (AQ_t 0.43 / AQ_t-1 0.42) |
| SGI: 0.99 (Revenue 4.90b / 4.94b) |
| TATA: -0.04 (NI 203.0m - CFO 375.0m) / TA 3.84b) |
| Beneish M = -2.82 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at EUR 41.96 with a total of 104,322 shares traded. Over the past week, the price has changed by -0.80%, over one month by -3.76%, over three months by +27.00% and over the past year by +1.27%.
Current recommended Stop Loss: 40.50 (which is 3.5% or 1.2 ATR below the current price).
Arcadis has no consensus analysts rating.
P/E Trailing = 18.5966
P/E Forward = 12.0919
P/S = 0.7533
P/B = 3.4163
P/EG = 2.9386
Revenue TTM = 4.90b EUR
EBIT TTM = 346.0m EUR
EBITDA TTM = 435.0m EUR
Long Term Debt = 855.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 291.0m EUR (from shortTermDebt, last quarter)
Debt = 1.56b EUR (from shortLongTermDebtTotal, last quarter) + Leases 238.0m
Net Debt = 1.29b EUR (calculated: Debt 1.56b - CCE 273.0m)
Enterprise Value = 4.98b EUR (3.69b + Debt 1.56b - CCE 273.0m)
Interest Coverage Ratio = 3.49 (Ebit TTM 346.0m / Interest Expense TTM 99.0m)
EV/FCF = 13.95x (Enterprise Value 4.98b / FCF TTM 357.0m)
FCF Yield = 7.17% (FCF TTM 357.0m / Enterprise Value 4.98b)
FCF Margin = 7.28% (FCF TTM 357.0m / Revenue TTM 4.90b)
Net Margin = 4.14% (Net Income TTM 203.0m / Revenue TTM 4.90b)
Gross Margin = 15.20% ((Revenue TTM 4.90b - Cost of Revenue TTM 4.16b) / Revenue TTM)
Gross Margin QoQ = 14.12% (prev 16.31%)
Tobins Q-Ratio = 1.30 (Enterprise Value 4.98b / Total Assets 3.84b)
Interest Expense / Debt = 6.34% (Interest Expense 99.0m / Debt 1.56b)
Taxrate = 25.09% (68.0m / 271.0m)
NOPAT = 259.2m (EBIT 346.0m * (1 - 25.09%))
Current Ratio = 1.19 (Total Current Assets 1.91b / Total Current Liabilities 1.60b)
Debt / Equity = 1.48 (Debt 1.56b / totalStockholderEquity, last quarter 1.05b)
Debt / EBITDA = 2.96 (Net Debt 1.29b / EBITDA 435.0m)
Debt / FCF = 3.61 (Net Debt 1.29b / FCF TTM 357.0m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.28% (Net Income 203.0m / Total Assets 3.84b)
RoE = 18.43% (Net Income TTM 203.0m / Total Stockholder Equity 1.10b)
RoCE = 17.68% (EBIT 346.0m / Capital Employed (Equity 1.10b + L.T.Debt 855.0m))
RoIC = 11.32% (NOPAT 259.2m / Invested Capital 2.29b)
WACC = 7.42% (E(3.69b)/V(5.25b) * Re(8.55%) + D(1.56b)/V(5.25b) * Rd(6.34%) * (1-Tc(0.25)))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -50.70 | Cagr: -1.84%
[DCF] Terminal Value 77.88% ; FCFF base≈339.0m ; Y1≈386.7m ; Y5≈562.0m
[DCF] Fair Price = 84.25 (EV 8.47b - Net Debt 1.29b = Equity 7.18b / Shares 85.2m; r=8.35% [WACC [floored]]; 5y FCF grow 14.42% → 2.50% )
EPS Correlation: -3.82 | EPS CAGR: -1.02% | SUE: 0.0 | # QB: 0
Revenue Correlation: 45.85 | Revenue CAGR: 2.40% | SUE: 2.80 | # QB: 5
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=3.06 | Chg30d=-0.24% | Revisions=+30% | GrowthEPS=+14.1% | GrowthRev=+0.8%
EPS next Year (2027-12-31): EPS=3.69 | Chg30d=+2.59% | Revisions=+36% | GrowthEPS=+20.8% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +39% (up=11, down=4)